(Mar. 22) AstraZeneca Plc’s coronavirus vaccine fared better than expected in a U.S. clinical trial, providing reassurance about its safety and efficacy as the drugmaker prepares to seek clearance from the Food and Drug Administration.
The…
(Mar. 22) AstraZeneca Plc’s coronavirus vaccine fared better than expected in a U.S. clinical trial, providing reassurance about its safety and efficacy as the drugmaker prepares to seek clearance from the Food and Drug Administration.
The…